John H. Duerden serves as Executive at Obagi Medical Products, Inc., where they oversee executive responsibilities. Since joining the company, John H. Duerden has executed 9 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 25, 2013 involved selling 13,220 shares valued at $317.3K.
John H. Duerden currently holds 2,206 shares of Obagi Medical Products, Inc. (OMPI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, John H. Duerden has been a net neutral trader of OMPI stock. They have purchased $0 and sold $0 worth of shares.
John H. Duerden's most recent insider trade was on Apr 25, 2013, when they sold 13,220 shares at $24.00 per share.
Get notified when new Form 4 filings are submitted
| 2,206 |
| $24.00 |
| Discretionary |
| Jun 6, 2012 | OMPI | $0 | Award | 2,206 | $N/A | Discretionary |
| Jun 7, 2011 | OMPI | $0 | Award | 3,209 | $N/A | Discretionary |
| Jun 8, 2010 | OMPI | $0 | Award | 2,463 | $N/A | Discretionary |
| Feb 24, 2010 | CROX | $236.5K | Payment | 31,080 | $7.61 | Discretionary |
| Jun 18, 2009 | OMPI | $0 | Award | 4,055 | $N/A | Discretionary |
| Jun 10, 2008 | OMPI | $0 | Award | 1,714 | $N/A | Discretionary |
| Dec 12, 2007 | OMPI | $0 | Award | 1,779 | $N/A | Discretionary |